Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Aquestive Therapeutics, Inc. - Common Stock
(NQ:
AQST
)
3.765
-0.145 (-3.71%)
Streaming Delayed Price
Updated: 9:54 AM EST, Jan 12, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Aquestive Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
What's going on in today's session
↗
January 09, 2026
Via
Chartmill
Keep an eye on the top gainers and losers in Friday's session.
↗
January 09, 2026
Via
Chartmill
The market is filled with gapping stocks in Friday's session.
↗
January 09, 2026
Via
Chartmill
Friday's pre-market session: top gainers and losers
↗
January 09, 2026
Via
Chartmill
Why Did AQST Stock Plunge 40% In Pre-Market Today?
↗
January 09, 2026
Via
Stocktwits
Earnings Scheduled For November 5, 2025
↗
November 05, 2025
Via
Benzinga
Aquestive Stock Jumps After-Hours As CEO Sees $1B ‘Blockbuster’ Potential For Oral Allergy Film — Retail Sees Stock As Buyout Candidate
↗
September 26, 2025
Via
Stocktwits
FDA Says No Advisory Committee Meeting Needed For Aquestive’s Oral Epinephrine Film
↗
September 04, 2025
Via
Stocktwits
Small-Cap Renaissance: Russell 2000 Scales New Heights While Big Tech Stumbles
January 08, 2026
In a dramatic shift that has recalibrated the pulse of Wall Street, the Russell 2000 index (RUT) surged to a new record high on January 8, 2026, signaling a definitive breakout for small-cap stocks. As...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
Small-Cap Slump: Russell 2000 Tumbles as Sticky Inflation Data Revives 'Higher-for-Longer' Fears
January 07, 2026
The Russell 2000 index, the primary benchmark for American small-cap stocks, suffered a significant sell-off on Wednesday, January 7, 2026, as a batch of conflicting economic data sparked fears that...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Stocks
Aquestive Therapeutics Stock Is Rising Pre-Market – Its $75M Funding Agreement Draws Divided Opinions From Retail
↗
August 14, 2025
Via
Stocktwits
Earnings Scheduled For May 12, 2025
↗
May 12, 2025
Via
Benzinga
Jim Cramer: Joby Is 'Losing Too Much Money'
↗
November 12, 2025
Jim Cramer finds Aquestive Therapeutics very interesting, while Amphenol Corporation is a great stock. Joby Aviation is losing money.
Via
Benzinga
Friday's session: gap up and gap down stocks
↗
September 26, 2025
Let's have a look at the gap up and gap down stocks in today's session.
Via
Chartmill
Crinetics Pharmaceuticals, BlackBerry, Perpetua Resources And Other Big Stocks Moving Higher On Friday
↗
September 26, 2025
U.S. stocks were higher, with the Dow Jones index gaining more than 200 points on Friday. Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) rose sharply during Friday's session after the FDA...
Via
Benzinga
Topics
Stocks
ARS Pharma Urges FDA To Delay Approval Of Aquestive's Allergic Reaction Treatment
↗
September 23, 2025
ARS Pharmaceuticals petitioned the FDA to delay approval of Aquestive's epinephrine film, citing safety, dosing, and cardiovascular concerns.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
September 19, 2025
Via
Benzinga
CoreWeave, Barrick Mining, FedEx And Other Big Stocks Moving Higher On Friday
↗
September 19, 2025
Via
Benzinga
Which stocks are gapping on Friday?
↗
September 19, 2025
The market is filled with gapping stocks in Friday's session. Let's discover which stocks are showing gap-ups and gap-downs.
Via
Chartmill
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
September 04, 2025
Via
Benzinga
Shoe Carnival, American Eagle, Ciena, Victoria's Secret And Other Big Stocks Moving Higher On Thursday
↗
September 04, 2025
Via
Benzinga
FDA Confirms Direct Review Path For Aquestive's Allergy Treatment
↗
September 04, 2025
Aquestive's Anaphylm could become the first oral epinephrine for severe allergic reactions after the FDA set a 2026 decision date without panel review.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
September 04, 2025
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
↗
August 14, 2025
Via
Benzinga
Earnings Scheduled For August 11, 2025
↗
August 11, 2025
Via
Benzinga
Uncovering Potential: Aquestive Therapeutics's Earnings Preview
↗
August 08, 2025
Via
Benzinga
Uncovering Potential: Aquestive Therapeutics's Earnings Preview
↗
May 09, 2025
Via
Benzinga
Aquestive Therapeutics Concludes FDA Application For Allergy Drug With Encouraging Pediatric Trial Data
↗
April 01, 2025
Aquestive's Anaphylm sublingual film met key pediatric study goals, supporting its NDA submission to the FDA for potential approval in 2025.
Via
Benzinga
Aquestive Therapeutics Stock Dips After-Hours On Q4 Miss — Retail Eyes Silver Linings
↗
March 05, 2025
Stocktwits users are viewing the company's cash position, expectations for a late 2026 Anaphylm launch, and an upcoming trial as positive signals.
Via
Stocktwits
Curious about the stocks that are showing activity after the closing bell on Wednesday?
↗
March 05, 2025
As the regular session of the US market on Wednesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Via
Chartmill
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
